About Bellicum Pharmaceuticals

Bellicum Pharmaceuticals, Inc. is a clinical stage company developing next generation therapeutic vaccines and other immunotherapeutic approaches for the treatment of cancer and chronic infectious diseases. Bellicum's novel approach is to utilize precise knowledge of the signaling pathways that regulate the immune response to target specific factors that can influence the potency and duration of this response. Our lead product, BP-GMAX-CD1, is in Phase I clinical trials.

website icon
Website
employees icon
Employees
industry icon
Industry
IT Services and IT Consulting
location icon
Phone number
(832) 384-1100
location icon
Headquarter
Houston, Texas
description icon
Founded
July

Bellicum Pharmaceuticals Alternatives

Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics

Frequently Asked Questions about Bellicum Pharmaceuticals

Who are the decision makers in Bellicum Pharmaceuticals?

The decision makers in Bellicum Pharmaceuticals are Daisy Lan, etc. Click to Find Bellicum Pharmaceuticals decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more